R

Restore Vision

3 employees

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
AAV
Therapeutics
retinitis pigmentosa
ophthalmology
Gene therapy

Date founded

2016

Funding rounds raised

Total raised

$2.7M

from 3 investors over 3 rounds

R

Restore Vision raised $2.6M on February 3, 2022

Investors: Remiges Ventures, Inc. and ANRI

R

Restore Vision raised $2.7M on February 3, 2022

Investors: KOBE Biomedical Innovation Cluster

FAQ